April 27, 2022 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall for the Medtronic Harmony delivery catheter, part of the transcatheter pulmonary valve (TPV) system, for risk of capsule break during use.

April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, announced the completion of patient enrollment in the

April 25, 2022 – There’s no safe way to get a close-up view of the human heart as it goes about its work: you can’t just pop it out, take a look, then slot it back in. Scientists have tried different ways to get around this fundamental problem: they’ve hooked up cadaver hearts to machines to make them pump again, attached lab-grown heart tissues to springs to watch them expand and contract. Each approach has its flaws: reanimated hearts can only beat for a few hours; springs can’t replicate the forces at work on the real muscle.

April 25, 2022 — Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient (consumer/user) level due to the presence of a nitrosamine, Nnitroso-quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level.

April 25, 2022 – Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 years with non-valvular atrial fibrillation (NVAF) and previous stroke/transient ischemic attack (TIA) more commonly had subsequent ischemic and hemorrhagic events than those

April 25, 2022 – Advancements in techniques and treatment have transformed care for patients with cardiovascular disease over the last decade, and national and state-wide initiatives have been put in place to help close disparity gaps and improve treatment for all patients. But a study by investigators from Brigham and Women’s Hospital found that gaps remain, and that female patients and patients who live in lower income neighborhoods have higher rates of death following cardiovascular and thoracic procedures.

April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology program and the opening of its new cardiac catheterization laboratory, designed to support cardiac health and bring world-class interventional cardiology care to the Hudson Valley and upper Westchester region.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now